Dietary apigenin potentiates the inhibitory effect of interferon-α on cancer cell viability through inhibition of 26S proteasomemediated interferon receptor degradation

Food and Nutrition Research

Volumn 60, Issue , 2016, Pages

  Li, Sheng ^a   Yang, Li Juan ^a   Wang, Ping ^b   He, Yu Jiao ^a   Huang, Jun Mei ^a,b   Liu, Han Wei ^c   Shen, Xiao Fei ^a   Wang, Fei ^a,d  

^a CHENGDU INSTITUTE OF BIOLOGY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Ningbo Entry Exit Inspection and Quarantine Bureau Technical Center   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Apigenin; Interferon; Proteasome; STAT; Ubiquitination

Indexed keywords

26S PROTEASOME; ALPHA INTERFERON; APIGENIN; INTERFERON RECEPTOR; JANUS KINASE; PROTEASOME; STAT1 PROTEIN; STAT2 PROTEIN; TRYPSIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HUMAN; HUMAN CELL; MOLECULAR DOCKING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION; UTERINE CERVIX CARCINOMA;

EID: 84979225453     PISSN: 16546628     EISSN: None     Source Type: Journal    
DOI: 10.3402/fnr.v60.31288     Document Type: Article

References (38)

1. Shukla S, Gupta S. Apigenin: a promising molecule for cancer prevention. Pharm Res 2010; 27: 96278.
2. Chen D, Daniel KG, Chen MS, Kuhn DJ, Landis-Piwowar KR, Dou QP. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 2005; 69: 142132.
3. Chen D, Landis-Piwowar KR, Chen MS, Dou QP. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Res 2007; 9: R80.
4. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Sakai T. The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand. Mol Cancer Ther 2006; 5: 94551.
5. Bonfili L, Cecarini V, Amici M, Cuccioloni M, Angeletti M, Keller JN, et al. Natural polyphenols as proteasome modulators and their role as anti-cancer compounds. FEBS J 2008; 275: 551226.
6. Voges D, Zwickl P, Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999; 68: 101568.
7. Kisselev AF, van der Linden WA, Overkleeft HS. Proteasome inhibitors: an expanding army attacking a unique target. Chem Biol 2012; 19: 99115.
8. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007; 6: 97590.
9. Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist 2001; 6: 3455.
10. Konishi H, Okamoto K, Ohmori Y, Yoshino H, Ohmori H, Ashihara M, et al. An orally available, small-molecule interferon inhibits viral replication. Sci Rep 2012; 2: 259.
11. Lucas-Hourani M, Dauzonne D, Jorda P, Cousin G, Lupan A, Helynck O, et al. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. PLoS Pathog 2013; 9: e1003678.
12. Tai Z, Lin Y, He Y, Huang J, Guo J, Yang L, et al. Luteolin sensitizes the antiproliferative effect of interferon a/b by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Cell Signal 2014; 26: 61928.
13. Ragimbeau J, Dondi E, Alcover A, Eid P, Uze G, Pellegrini S. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J 2003; 22: 53747.
14. Kumar KGS, Krolewski JJ, Fuchs SY. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem 2004; 279: 4661420.
15. Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol 2002; 22: 331626.
16. Soond SM, Townsend PA, Barry SP, Knight RA, Latchman DS, Stephanou A. ERK and the F-box protein bTRCP target STAT1 for degradation. J Biol Chem 2008; 283: 1607783.
17. Tai ZF, Zhang GL, Wang F. Identification of small molecule activators of the janus kinase/signal transducer and activator of transcription pathway using a cell-based screen. Biol Pharm Bull 2012; 35: 6571.
18. He Y, Huang J, Wang P, Shen X, Li S, Yang L, et al. Emodin potentiates the antiproliferative effect of interferon a/b by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome. Oncotarget 2016; 7: 466479.
19. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31: 45561.
20. Vetrivel U, Pilla K. Open discovery: an integrated live Linux platform of Bioinformatics tools. Bioinformation 2008; 3:1446.
21. Erales J, Coffino P. Ubiquitin-independent proteasomal degradation. Biochim Biophys Acta 2014; 1843: 21621.
22. Wei HC, Tye L, Bresnick E, Birt DF. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 1990; 50: 499502.
23. Chang TL. Inhibitory effect of flavonoids on 26S proteasome activity. J Agric Food Chem 2009; 57: 970615.
24. Chen D, Chen MS, Cui QC, Yang H, Dou QP. Structureproteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells. Front Biosci 2007; 12: 193545.
25. Yu A, Malek TR. The Proteasome regulates receptor-mediated endocytosis of interleukin-2. J Biol Chem 2001; 276: 3815.
26. Longva KE, Blystad FD, Stang E, Larsen AM, Johannessen LE, Madshus IH. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J Cell Biol 2002; 156: 84354.
27. Kumar KGS, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY. SCFHOS ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-a receptor. EMBO J 2003; 22: 548090.
28. Fuchs SY. Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res 2013; 33: 21125.
29. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol 2005; 32: 81116.
30. Kanerva A, Raki M, Ranki T, Sarkioja M, Koponen J, Desmond RA, et al. Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity. J Gene Med 2007; 9: 39.
31. Liu AL, Liu B, Qin HL, Lee SMY, Wang YT, Du GH. Antiinfluenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med 2008; 74: 84751.
32. Lv X, Qiu M, Chen D, Zheng N, Jin Y, Wu Z. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antivir Res 2014; 109: 3041.
33. Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-a/b revisited. Nat Rev Mol Cell Biol 2001; 2: 37886.
34. Blank VC, Poll C, Marder M, Roguin LP. Antiproliferative activity of various flavonoids and related compounds: additive effect of interferon-a2b. Bioorg Med Chem Lett 2004; 14: 1336.
35. Nielsen SE, Young JF, Daneshvar B, Lauridsen ST, Knuthsen P, Sandström B, et al. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr 1999; 81: 44755.
36. Gradolatto A, Basly JP, Berges R, Teyssier C, Chagnon MC, Siess MH, et al. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab Dispos 2005; 33: 4954.
37. Chen T, Li LP, Lu XY, Jiang HD, Zeng S. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem 2007; 55: 2737.
38. Martin JHJ, Crotty S, Warren P, Nelson PN. Does an apple a day keep the doctor away because a phytoestrogen a day kîps the virus at bay? A review of the anti-viral properties of phytoestrogens. Phytochemistry 2007; 68: 26674.